Skip to content
healthcare.dev
Get a free key

Lamivudine

NDC 68180-602, Lamivudine, tablet, film coated, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-602
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205217
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-602 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ff3b5265-f533-4332-a861-d8c9c1664ffd

Use it

Look up 68180-602 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-602 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-602. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.